Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Robert M. Hamer, PhD
JCP
Original Research
Cost-Effectiveness of Internet-Based CBT
December 5, 2017
Cognitive-behavioral therapy tailored for bulimia nervosa (CBT-BN) is the best-supported treatment for this eating disorder, but the lack of highly trained practitioners and the limited distribution of this treatment...
Hunna J. Watson
,
Nicole McLagan
,
Stephanie C. Zerwas
, et al
JCP
Original Research
Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial
May 15, 2012
Richard S. E. Keefe
,
Sophia Vinogradov
,
Alice Medalia
, et al
JCP
Original Research
Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder: A Randomized, Double-Blind, Flexible-Dose, Multicenter Study
January 15, 2008
Diana O. Perkins
,
Hongbin Gu
,
Peter J. Weiden
, et al
JCP
Original Research
Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study
July 14, 2006
Kate X. Zhong
,
Dennis E. Sweitzer
,
Robert M. Hamer
, et al
